Literature DB >> 3405648

Cerebrospinal fluid pyrazinamide concentrations in children with tuberculous meningitis.

P R Donald1, H Seifart.   

Abstract

Cerebrospinal fluid pyrazinamide concentrations were determined by high pressure liquid chromatography in 53 samples from 13 children who had tuberculous meningitis complicated by increased intracranial pressure. Peak concentrations of up to 50 micrograms/ml were achieved between 1 1/2 and 2 1/2 hours after pyrazinamide administration and in most cases a concentration of 20 micrograms/ml or more was achieved. We conclude that pyrazinamide easily gains entry into the cerebrospinal fluid of children with tuberculous meningitis and should be included in treatment regimens for that disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3405648     DOI: 10.1097/00006454-198807000-00003

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

1.  The management of tuberculous meningitis.

Authors:  M Humphries
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

Review 2.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 3.  Management of tuberculosis meningitis.

Authors:  M R Holdiness
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

Review 4.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

5.  The blood/cerebrospinal fluid partitioning of pyrazinamide: a study during the course of treatment of tuberculous meningitis.

Authors:  P Phuapradit; K Supmonchai; S Kaojarern; C Mokkhavesa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

6.  Chemotherapeutic interventions against tuberculosis.

Authors:  Neeraj Shakya; Gaurav Garg; Babita Agrawal; Rakesh Kumar
Journal:  Pharmaceuticals (Basel)       Date:  2012-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.